Site Map
Product Pages Catalogue Numbers 2001 - 2100
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 2001 | GS 39783 |
| Positive modulator at GABAB receptors | |
| 2002 | Ro 31-8220 mesylate |
| Protein kinase inhibitor | |
| 2004 | Isradipine |
| Ca2+ channel blocker (L-type) | |
| 2005 | Ro 04-5595 hydrochloride |
| Selective NR2B antagonist | |
| 2006 | Paxilline |
| Potent blocker of BKCa channels | |
| 2007 | Fluticasone propionate |
| Selective high affinity glucocorticoid agonist | |
| 2008 | SKF 86002 dihydrochloride |
| p38 MAP kinase inhibitor; anti-inflammatory agent | |
| 2009 | PSB 1115 potassium salt |
| Selective human A2B receptor antagonist; water-soluble | |
| 2010 | PSB 10 hydrochloride |
| Potent, highly selective human A3 receptor antagonist/inverse agonist | |
| 2011 | Tomoxetine hydrochloride |
| Potent, selective noradrenaline re-uptake inhibitor | |
| 2012 | PSB 11 hydrochloride |
| Potent, selective human A3 receptor antagonist/inverse agonist | |
| 2013 | Guggulsterone |
| Broad spectrum steroid receptor ligand. Antagonises FXR and displays hypolipidaemic activity | |
| 2018 | Mirtazepine |
| Potent 5-HT2 antagonist. Also 5-HT3, H1 and α2-antagonist. Antidepressant | |
| 2019 | PSB 36 |
| Potent, A1-selective antagonist | |
| 2020 | Ch 55 |
| Potent retinoic acid receptor (RAR) agonist | |
| 2021 | LE 135 |
| RARβ-selective antagonist | |
| 2022 | SR 202 |
| Selective PPARγ antagonist; antidiabetic and antiobesity agent | |
| 2023 | Medetomidine hydrochloride |
| Potent, highly selective α2 agonist | |
| 2025 | Cinalukast |
| Potent, selective CysLT1 (LTD4) antagonist; orally active | |
| 2027 | Anti-mGlu2 |
| Antibody recognising rat mGlu2 receptors | |
| 2029 | Anti-mGlu2/3 |
| Antibody recognising human mGlu2 and mGlu3 receptors | |
| 2031 | Anti-mGlu7 |
| Antibody recognising human mGlu7 receptors | |
| 2032 | Anti-mGlu5 |
| Antibody recognising rat mGlu5 receptors | |
| 2033 | Pentostatin |
| Adenosine deaminase inhibitor | |
| 2034 | ROS 234 dioxalate |
| Potent H3 antagonist | |
| 2035 | BWX 46 |
| Highly selective Y5 agonist | |
| 2037 | SDZ 205-557 hydrochloride |
| 5-HT4/5-HT3 receptor antagonist | |
| 2038 | Iloprost |
| Prostacyclin (PGI2) analogue | |
| 2039 | CI 898 trihydrochloride |
| Dihydrofolate reductase inhibitor | |
| 2041 | Anti-phospho-GluR1 (Ser831) |
| Antibody recognising rat GluR1 subunits phosphorylated at Ser831 | |
| 2046 | Anti-GluR4 |
| Antibody recognising rat GluR4 subunits | |
| 2047 | Anti-GluR5 |
| Antibody recognising rat GluR5 subunits | |
| 2048 | Anti-GluR6/7 |
| Antibody recognising rat GluR6 and GluR7 subunits | |
| 2049 | Anti-glutamate receptor δ1/2 |
| Antibody recognising rat glutamate receptor δ1 and δ2 subunits | |
| 2052 | Anti-phospho-NR1 (Ser896) |
| Antibody recognising rat NR1 subunits phosphorylated at Ser896 | |
| 2053 | Anti-phospho-NR1 (Ser897) |
| Antibody recognising rat NR1 subunits phosphorylated at Ser897 | |
| 2054 | Anti-NR1, alternative CT |
| Antibody recognising rat NR1 subunits with alternative C-terminus | |
| 2056 | Anti-phospho-NR2A (Ser1232) |
| Antibody recognising rat NR2A subunits phosphorylated at Ser1232 | |
| 2059 | Anti-NR3A |
| Antibody recognising rat NR3A subunits | |
| 2060 | Anti-NR3B |
| Antibody recognising mouse NR3B subunits | |
| 2062 | Anti-KA2 |
| Antibody recognising rat KA2 subunits | |
| 2063 | Anti-glutamate transporter GLT-1 |
| Antibody recognising GLT-1 | |
| 2064 | Anti-glutamate transporter GLAST |
| Antibody recognising GLAST | |
| 2066 | Anti-c-Fos |
| Antibody recognising c-Fos | |
| 2067 | 187-1, N-WASP inhibitor |
| Inhibits actin assembly | |
| 2070 | K 41498 |
| Highly selective and potent CRF2 antagonist | |
| 2071 | Antisauvagine-30 |
| Potent, selective and competitive CRF2 antagonist | |
| 2072 | Aminopurvalanol A |
| Cyclin-dependent kinase inhibitor | |
| 2073 | (R)-(-)-Apomorphine hydrochloride |
| Dopamine agonist; non-subtype-selective | |
| 2074 | SKF 83959 hydrobromide |
D1-like partial agonist |
|
| 2075 | SKF 83822 hydrobromide |
| Selective D1-like agonist | |
| 2076 | Y-26763 |
| KATP channel opener | |
| 2077 | Y-27152 |
| Prodrug of KATP channel opener Y-26763; orally active in vivo | |
| 2078 | UBP 296 |
| Selective, potent kainate antagonist; selective for GLUK5-containing receptors | |
| 2079 | UBP 302 |
| Selective, potent kainate antagonist; active enantiomer of UBP 296 (Cat. No. 2078) | |
| 2080 | PHM 27 (human) |
| Potent calcitonin receptor agonist; endogenous analogue of human VIP | |
| 2081 | Exendin-3 (9-39) amide |
| Potent GLP-1 receptor antagonist | |
| 2082 | Glucagon-like peptide 1 (7-36) amide (human, rat, mouse) |
| Potent insulinotropic peptide | |
| 2084 | GIP (human) |
| Potent insulinotropic gut hormone | |
| 2085 | Galnon |
| Selective, non-peptide GalR1 agonist | |
| 2086 | GTP 14564 |
| Class III receptor tyrosine kinase (RTK) inhibitor | |
| 2087 | NTR 368 |
| p75NTR fragment; induces apoptosis | |
| 2088 | DMNB |
| DNA-dependent protein kinase inhibitor | |
| 2089 | RS 102895 hydrochloride |
| CCR2b chemokine receptor antagonist | |
| 2090 | CALP1 |
| Cell-permeable calmodulin agonist | |
| 2092 | Ionomycin free acid |
| Calcium ionophore | |
| 2094 | Oxyntomodulin |
| Endogenous gut peptide; modulates feeding and metabolism | |
| 2095 | PNU 37883 hydrochloride |
| Vascular KATP channel blocker | |
| 2096 | DAU 5884 hydrochloride |
| M3 receptor antagonist | |
| 2097 | SKI II |
| Selective non-lipid inhibitor of sphingosine kinase; antitumour | |
| 2098 | Apoptosis Activator 2 |
| Promotes apoptosome formation and activates caspase-9/caspase-3 pathway. Selectively induces tumour cell apoptosis | |
| 2100 | Anti-mGlu2 blocking peptide |
| Blocking peptide for anti-mGlu2 (Cat. No. 2027) | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]